leadership
confidence high
sentiment neutral
materiality 0.25
Clover Health adds ex-Sen. Torricelli and Johns Hopkins' Dr. Brian Miller to board, filling two vacancies
CLOVER HEALTH INVESTMENTS, CORP. /DE
- Board appointed Sen. Robert Torricelli (Class I) and Dr. Brian J. Miller (Class III) effective September 22, 2026, filling two previously disclosed vacancies; board now has nine directors.
- Torricelli, a New Jersey U.S. Senator 1997-2003 and House member 1983-1997, joins the Audit Committee; he has been a director of Clover's insurance subsidiaries since 2022.
- Miller is a Johns Hopkins Hospital hospitalist and Johns Hopkins associate professor, a MedPAC commissioner since May 2023, and vice chairman of the North Carolina State Health Plan board.
- Each receives a pro-rated 2026 retainer plus an RSU award valued at $200,000, pro-rated for days served from appointment through December 31, 2026, under Clover's director compensation policy.
- CEO Andrew Toy and Executive Chairperson Vivek Garipalli said the additions deepen board expertise in Medicare Advantage, clinical practice and healthcare policy.